Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06700841, including a bioavailability/food-effect assessment in plaqu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• PF-06700841

Snippet

Sponsor: Pfizer | Conditions: Plaque Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2017-03-08